← Back to patent-cliff list
苯磺酸左旋氨氯地平/缬沙坦
Tier C — Watch / tradeLevamlodipine Besylate/Valsartan
安国药品株式会社
Originator
2013
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：AT1、VDCCs
Brand：Levosartan
Indications (approved)：高血压
Regional status
US
-
EU
-
China
临床三期
2024-08-02
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Levamlodipine Besylate/Valsartan?
Approved indications include: 高血压.
When does the Levamlodipine Besylate/Valsartan patent expire?
No public expiry year is available for Levamlodipine Besylate/Valsartan yet; this page updates once verified.
How do I get a quote for Levamlodipine Besylate/Valsartan intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24